share_log

Alumis Shares Are Trading Lower. The Company Presented the 28-week Open Label Extension Period Data From Its Phase 2 STRIDE Trial of ESK-001.

Alumis Shares Are Trading Lower. The Company Presented the 28-week Open Label Extension Period Data From Its Phase 2 STRIDE Trial of ESK-001.

Alumis股票交易走低。该公司发布了ESk-001第2阶段STRIDE试验28周开放标签延伸期数据。
Benzinga ·  09/27 13:17

Alumis Shares Are Trading Lower. The Company Presented the 28-week Open Label Extension Period Data From Its Phase 2 STRIDE Trial of ESK-001.

Alumis股票交易走低。该公司发布了ESk-001第2阶段STRIDE试验28周开放标签延伸期数据。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发